Turn Therapeutics Inc. 8-K

What Happened

• Turn Therapeutics Inc. (TTRX) filed a Form 8-K dated February 17, 2026 reporting a Regulation FD disclosure. The company furnished a press release on February 17, 2026 as Exhibit 99.1 to the filing. The 8-K was filed under accession number 0001213900-26-016916.

Key Details

• Item reported: 7.01 — Regulation FD Disclosure (press release furnished).
• Exhibit furnished: 99.1 — Press Release dated February 17, 2026.
• Interactive data: Exhibit 104 — Cover Page Interactive Data File (Inline XBRL) embedded.
• Filing date: February 17, 2026; accession no. 0001213900-26-016916.

Why It Matters

• Furnishing a press release under Regulation FD means Turn Therapeutics made information publicly available to all investors simultaneously. Investors should read Exhibit 99.1 (the press release) for the company’s announced details.
• The 8-K itself contains the disclosure notice and exhibits listing but does not add additional narrative in the filing; any material updates (e.g., financial results, leadership changes, mergers) would appear in the press release or in separate SEC filings.